Strategic Partnerships Opportunity to leverage Splash Beverage Group's recent collaborations with Lupvindol Biosciences and Argent BioPharma for co-branded product initiatives, regulatory pathways, and broader distribution of CannEpil-based veterinary and human cannabinoid therapies across multiple markets.

Cannabinoid Expansion Clinical and regulatory activities around CannEpil present a channel for sales reps to position Splash as a gateway to cannabinoid-based therapeutics in Europe and veterinary spaces, potentially opening licensing, distribution, and co-development deals.

Leadership Transitions Interim CEO appointment and upcoming leadership changes signal a potential for strategic pivots; outreach could align with new direction opportunities, onboarding strategic partners, and accelerated deal-making during leadership transition.

Healthy Brand Positioning The focus on natural, healthy drinks coupled with a diversified portfolio (including tequilas like Chispo Tequila) offers cross-sell potential into wellness channels, fitness retailers, and hospitality sectors seeking healthier beverage choices.

NYSE Compliance Readiness Addressing NYSE compliance challenges and restoration plans may create a window to engage on capital markets capital raises, strategic investments, or distribution partnerships tied to equity-linked incentives and growth milestones.